Zacks: Analysts Expect Ocular Therapeutix, Inc. (NASDAQ:OCUL) Will Post Quarterly Sales of ...

Retrieved on: 2021-05-18 07:16:07

Tags for this article:

Finance

Money

Ocular Therapeutix Inc

Click the tags to see associated articles and topics

Zacks: Analysts Expect Ocular Therapeutix, Inc. (NASDAQ:OCUL) Will Post Quarterly Sales of .... View article details on HISWAI: https://www.marketbeat.com/instant-alerts/nasdaq-ocul-consensus-analyst-rating-2021-05-2-3/

Excerpt

AQR Capital Management LLC now owns 65,077 shares of the biopharmaceutical company's stock worth $1,068,000 after purchasing an additional ...

Article found on: www.marketbeat.com

View Original Article